Design and synthesis of novel coumarin–benzimidazole hybrids as human galectin-1 inhibitors

References

• Nagai H, Kim YH. Cancer prevention from the perspective of global cancer burden patterns. J. Thorac. Dis. 9(3), 448–451 (2017).
   PubMed Web of Science ®Google Scholar
• Arnold M, Morgan E, Rumgay H et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66, 15–23 (2022).
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J. Clin. 73(1), 17–48 (2023).
   PubMed Web of Science ®Google Scholar
• Trieu PD, Mello-Thoms CR, Barron ML, Lewis SJ. Look how far we have come: BREAST cancer detection education on the international stage. Front. Oncol. 12, 1023714 (2023).
   PubMed Web of Science ®Google Scholar
• Goud NS, Bhattacharya A. Human galectin-1 in multiple cancers: a privileged molecular target in oncology. Mini Rev. Med. Chem. 21(15), 2169–2186 (2021).
   PubMed Web of Science ®Google Scholar
• Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 16(11), 137R–157R (2006).
   PubMed Web of Science ®Google Scholar
• Goud NS, Soukya PSL, Ghouse M, Komal D, Alvala R, Alvala M. Human galectin-1 and its inhibitors: privileged target for cancer and HIV. Mini Rev. Med. Chem. 19(16), 1369–1378 (2019).
   PubMed Web of Science ®Google Scholar
• Blanchard H, Bum-Erdene K, Bohari MH, Yu X. Galectin-1 inhibitors and their potential therapeutic applications: a patent review. Expert Opin. Ther. Pat. 26(5), 537–554 (2016).
   PubMed Web of Science ®Google Scholar
• Sethi BA, Sanam S, Alvala R, Alvala M. An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016-present). Expert Opin. Ther. Pat. 31(8), 709–721 (2021).
   PubMed Web of Science ®Google Scholar
• Goud NS, Kumar P, Bharath RD. Recent developments of target based coumarin derivatives as potential anticancer agents. Mini Rev. Med. Chem. 20(17), 1754–1766 (2020).
   PubMed Web of Science ®Google Scholar
• Flores-Morales V, Villasana-Ruíz AP, Garza-Veloz I, González-Delgado S, Martinez-Fierro ML. Therapeutic effects of coumarins with different substitution patterns. Molecules 28(5), 2413 (2023).
   PubMed Web of Science ®Google Scholar
• Kaur M, Kohli S, Sandhu S, Bansal Y, Bansal G. Coumarin: a promising scaffold for anticancer agents. Anticancer Agents Med. Chem. 15(8), 1032–1048 (2015).
   PubMed Web of Science ®Google Scholar
• Annunziata F, Pinna C, Dallavalle S, Tamborini L, Pinto A. An overview of coumarin as a versatile and readily accessible scaffold with broad-ranging biological activities. Int. J. Mol. Sci. 21(13), 4618 (2020).
   PubMed Web of Science ®Google Scholar
• Singh RK, Lange TS, Kim KK, Brard L. A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest. New Drugs 29(1), 63–72 (2011).
   PubMed Web of Science ®Google Scholar
• Zhao H, Moroni E, Colombo G, Blagg BSJ. Identification of a new scaffold for hsp90 C-terminal inhibition. ACS Med. Chem. Lett. 5(1), 84–88 (2014).
   PubMed Web of Science ®Google Scholar
• Brishty SR, Hossain MJ, Khandaker MU, Faruque MRI, Osman H, Rahman SMA. A comprehensive account on recent progress in pharmacological activities of benzimidazole derivatives. Front. Pharmacol. 12, 762807 (2021).
   PubMed Web of Science ®Google Scholar
• Keri RS, Hiremathad A, Budagumpi S, Nagaraja BM. Comprehensive review in current developments of benzimidazole-based medicinal chemistry. Chem. Biol. Drug Des. 86(1), 19–65 (2015).
   PubMed Web of Science ®Google Scholar
• Vasava MS, Bhoi MN, Rathwa SK et al. Benzimidazole: a milestone in the field of medicinal chemistry. Mini Rev. Med. Chem. 20(7), 532–565 (2020).
   PubMed Web of Science ®Google Scholar
• Wu L, Jiang Z, Shen J et al. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents. Eur. J. Med. Chem. 114, 328–336 (2016).
   PubMed Web of Science ®Google Scholar
• Goud NS, Joshi RK, Bharath RD, Kumar P. Fluorine-18: a radionuclide with diverse range of radiochemistry and synthesis strategies for target based PET diagnosis. Eur. J. Med. Chem. 187, 111979 (2020).
   PubMed Web of Science ®Google Scholar
• Jacobson O, Kiesewetter DO, Chen X. Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug. Chem. 26(1), 1–18 (2015).
   PubMed Web of Science ®Google Scholar
• Goud NS, Ghouse MS, Nagaraju C, Bharath RD, Alvala M, Kumar P. Automated radiosynthesis and molecular docking studies of coumarin–triazole hybrid with fluorine-18: a feasibility study. Curr. Radiopharm. 15(1), 40–49 (2022).
   PubMed Web of Science ®Google Scholar
• Goud NS, Kanth Makani VK, Pranay J et al. Synthesis, 18F-radiolabeling and apoptosis inducing studies of novel 4,7-disubstituted coumarins. Bioorg. Chem. 97, 103663 (2020).
   PubMed Web of Science ®Google Scholar
• Sridhar Goud N, Pooladanda V, Muni Chandra K et al. Novel benzimidazole–triazole hybrids as apoptosis inducing agents in lung cancer: design, synthesis, 18F-radiolabeling and galectin-1 inhibition studies. Bioorg. Chem. 102, 104125 (2020).
   PubMed Web of Science ®Google Scholar
• Nerella SG, Singh P, Sanam T, Digwal CS. PET molecular imaging in drug development: the imaging and chemistry perspective. Front. Med. 9, 812270 (2022).
   Web of Science ®Google Scholar
• Goud NS, Ghouse SM, Vishnu J et al. Synthesis of 1-benzyl-1H-benzimidazoles as galectin-1 mediated anticancer agents. Bioorg. Chem. 89, 103016 (2019).
   PubMed Web of Science ®Google Scholar
• Goud NS, Ghouse MS, Vishnu J et al. Synthesis and biological evaluation of novel heterocyclic imines linked coumarin-thiazole hybrids as anticancer agents. Anticancer Agents Med. Chem. 19(4), 557–566 (2019).
   PubMed Web of Science ®Google Scholar
• Daipule K, Goud NS, Sethi A, Gurrapu S, Mamidala E, Alvala M. Synthesis, molecular docking simulation, and biological evaluation studies of novel amide and ether conjugates of 2,3-diaryl-1,3-thiazolidin-4-ones. J. Heterocycl. Chem. 57(2), 774–790 (2020).
   Web of Science ®Google Scholar
• Emadi M, Halimi M, Moazzam A et al. Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents. Sci. Rep. 13(1), 10030 (2023).
   PubMed Web of Science ®Google Scholar
• Rai D, Khatua S, Taraphder S. Structure and dynamics of the isozymes II and IX of human carbonic anhydrase. ACS Omega 7(35), 31149–31166 (2022).
   PubMed Web of Science ®Google Scholar
• Thacker PS, Sridhar Goud N, Argulwar OS et al. Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors. Bioorg. Chem. 104, 104272 (2020).
   PubMed Web of Science ®Google Scholar
• Ram S, Wise DS, Townsend LB. Synthesis of 2-thiobenzimidazole derivatives as potential antifilarial agents. J. Heterocycl. Chem. 22(5), 1269–1274 (1985).
   Web of Science ®Google Scholar
• Narella SG, Shaik MG, Mohammed A, Alvala M, Angeli A, Supuran CT. Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors. Bioorg. Chem. 87, 765–772 (2019).
   PubMed Web of Science ®Google Scholar
• Goud NS, Pooladanda V, Mahammad GS et al. Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents. Chem. Biol. Drug Des. 94(5), 1919–1929 (2019).
   PubMed Web of Science ®Google Scholar